Denmark health care stocks

Data as of 6 Nov 2026.

11 Denmark Health Care companies, worth $279B in total.
Cap-weighted return: 1 month +14.2%, 6 months +15.0%.
Median revenue growth +6%; median forward P/E 22.8×.
Largest industries: Medical Specialties (5), Pharmaceuticals: Major (3), Biotechnology (3).

All Denmark health care companies

Sorted by market value. Click a company for its competitor analysis.
Company	Industry	Market cap	1M	6M	Revenue growth	Op. margin	Fwd P/E
Novo Nordisk A/S NOVO-B.CO	Pharmaceuticals: Major	$190B	+8%	-7%	+6%	48%	11.9×
Genmab A/S GMAB.CO	Biotechnology	$32.1B	+50%	+115%	+14%	32%	44.8×
Coloplast A/S COLO-B.CO	Medical Specialties	$17.7B	+20%	+26%	+4%	25%	19.9×
Demant A/S DEMANT.CO	Medical Specialties	$11.6B	+17%	+62%	+10%	18%	25.7×
ALK-abello A/S ALK-B.CO	Pharmaceuticals: Major	$8.14B	+6%	-5%	+17%	27%	35.7×
H. Lundbeck A/S HLUN-A.CO	Pharmaceuticals: Major	$8.02B	+18%	+47%	+9%	27%	n/a
Ambu A/S AMBU-B.CO	Medical Specialties	$3.42B	+24%	+40%	+5%	11%	28.1×
Bavarian Nordic A/S BAVA.CO	Biotechnology	$2.93B	+5%	+27%	-3%	16%	17.1×
Zealand Pharma A/S ZEAL.CO	Biotechnology	$2.32B	-2%	-32%	-49%	51%	8.8×
Embla Medical hf EMBLA.CO	Medical Specialties	$1.75B	+1%	+3%	+6%	14%	17.9×
ChemoMetec A/S CHEMM.CO	Medical Specialties	$1.69B	+27%	+124%	+3%	49%	52.0×